KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Other Non Operating Income (2018 - 2025)

Neogenomics' Other Non Operating Income history spans 8 years, with the latest figure at $84000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 119.49% year-over-year to $84000.0; the TTM value through Dec 2025 reached $296000.0, up 178.1%, while the annual FY2025 figure was $296000.0, 178.1% up from the prior year.
  • Other Non Operating Income reached $84000.0 in Q4 2025 per NEO's latest filing, up from -$335000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $730000.0 in Q2 2023 to a low of -$4.9 million in Q1 2021.
  • Average Other Non Operating Income over 5 years is -$258800.0, with a median of $12000.0 recorded in 2022.
  • Peak YoY movement for Other Non Operating Income: plummeted 2276.68% in 2021, then skyrocketed 24200.0% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$930000.0 in 2021, then soared by 99.89% to -$1000.0 in 2022, then surged by 12500.0% to $124000.0 in 2023, then tumbled by 447.58% to -$431000.0 in 2024, then skyrocketed by 119.49% to $84000.0 in 2025.
  • Per Business Quant, the three most recent readings for NEO's Other Non Operating Income are $84000.0 (Q4 2025), -$335000.0 (Q3 2025), and $482000.0 (Q2 2025).